Advocacy at a Glance STEVEN GROSSMAN 3/13/21 Advocacy at a Glance STEVEN GROSSMAN 3/13/21 COVID relief legislation becomes law, providing $500 million in no-year money to support FDA’s work on COVID and related items. Read More Advocacy at a Glance STEVEN GROSSMAN 3/6/21 Advocacy at a Glance STEVEN GROSSMAN 3/6/21 The Senate has taken up the COVID relief reconciliation bill and is expected to be done before March 8, assuming the Senate will work this weekend if necessary. Read More Advocacy at a Glance STEVEN GROSSMAN 10/9/20 Advocacy at a Glance STEVEN GROSSMAN 10/9/20 Life Under the Continuing Resolution Read More Advocacy at a Glance STEVEN GROSSMAN 9/18/20 Advocacy at a Glance STEVEN GROSSMAN 9/18/20 Dr. Cavazzoni and Dr. Stein to Address FDA Members and Media on October 16 Read More Advocacy at a Glance STEVEN GROSSMAN 3/27/20 Advocacy at a Glance STEVEN GROSSMAN 3/27/20 FDA Gains $80 Million in Third Pandemic Relief Bill Read More
Advocacy at a Glance STEVEN GROSSMAN 3/13/21 Advocacy at a Glance STEVEN GROSSMAN 3/13/21 COVID relief legislation becomes law, providing $500 million in no-year money to support FDA’s work on COVID and related items. Read More
Advocacy at a Glance STEVEN GROSSMAN 3/6/21 Advocacy at a Glance STEVEN GROSSMAN 3/6/21 The Senate has taken up the COVID relief reconciliation bill and is expected to be done before March 8, assuming the Senate will work this weekend if necessary. Read More
Advocacy at a Glance STEVEN GROSSMAN 10/9/20 Advocacy at a Glance STEVEN GROSSMAN 10/9/20 Life Under the Continuing Resolution Read More
Advocacy at a Glance STEVEN GROSSMAN 9/18/20 Advocacy at a Glance STEVEN GROSSMAN 9/18/20 Dr. Cavazzoni and Dr. Stein to Address FDA Members and Media on October 16 Read More
Advocacy at a Glance STEVEN GROSSMAN 3/27/20 Advocacy at a Glance STEVEN GROSSMAN 3/27/20 FDA Gains $80 Million in Third Pandemic Relief Bill Read More
